ATE338765T1 - Konzentrierung wässriger fraktionen von lisinopril durch umgekehrte osmose - Google Patents

Konzentrierung wässriger fraktionen von lisinopril durch umgekehrte osmose

Info

Publication number
ATE338765T1
ATE338765T1 AT02778183T AT02778183T ATE338765T1 AT E338765 T1 ATE338765 T1 AT E338765T1 AT 02778183 T AT02778183 T AT 02778183T AT 02778183 T AT02778183 T AT 02778183T AT E338765 T1 ATE338765 T1 AT E338765T1
Authority
AT
Austria
Prior art keywords
lisinopril
reverse osmosis
concentration
aqueous fractions
fractions
Prior art date
Application number
AT02778183T
Other languages
English (en)
Inventor
Janez Rzen
David Senica
Pavel Drnovsek
Original Assignee
Lek Farmacevtska Druzba Dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Farmacevtska Druzba Dd filed Critical Lek Farmacevtska Druzba Dd
Application granted granted Critical
Publication of ATE338765T1 publication Critical patent/ATE338765T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02778183T 2001-11-26 2002-11-08 Konzentrierung wässriger fraktionen von lisinopril durch umgekehrte osmose ATE338765T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200100300A SI21101A (sl) 2001-11-26 2001-11-26 Koncentriranje vodnih frakcij lisinoprila z reverzno osmozo

Publications (1)

Publication Number Publication Date
ATE338765T1 true ATE338765T1 (de) 2006-09-15

Family

ID=20433017

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02778183T ATE338765T1 (de) 2001-11-26 2002-11-08 Konzentrierung wässriger fraktionen von lisinopril durch umgekehrte osmose

Country Status (7)

Country Link
US (1) US20050010056A1 (de)
EP (1) EP1451208B1 (de)
AT (1) ATE338765T1 (de)
AU (1) AU2002339835A1 (de)
DE (1) DE60214587D1 (de)
SI (1) SI21101A (de)
WO (1) WO2003045981A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101985463A (zh) * 2010-10-29 2011-03-16 浙江昌明药业有限公司 一种利用膜分离技术分离制备赖诺普利的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US5336601A (en) * 1986-08-18 1994-08-09 The Coca-Cola Company Enzymatic membrane method for the snythesis and separation of peptides
JP3792777B2 (ja) * 1996-05-10 2006-07-05 株式会社カネカ 1−アルコキシカルボニル−3−フェニルプロピル誘導体の製造方法
US5907044A (en) * 1997-07-30 1999-05-25 Degussa Aktiengellschaft Method of isolating 1- N2 -((S)-ethoxycarbonyl)-3-phenylpropyl)-N6 -trifluoroacetyl!-L-lysyl-L-proline (lisinopril (TFA) ethyl ester, LPE)

Also Published As

Publication number Publication date
AU2002339835A1 (en) 2003-06-10
US20050010056A1 (en) 2005-01-13
EP1451208A2 (de) 2004-09-01
AU2002339835A8 (en) 2003-06-10
WO2003045981A3 (en) 2003-12-24
DE60214587D1 (de) 2006-10-19
EP1451208B1 (de) 2006-09-06
SI21101A (sl) 2003-06-30
WO2003045981A2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
ATE496683T1 (de) Nanofiltrations-meereswasserentsalzungsverfahre
DE60114348D1 (de) Verfahren zur Reinigung von Gasen
DK1335881T3 (da) Fremgangsmåde til afsaltning af havvand
DE69022473D1 (de) Vorbeugung gegen Biokontamination von Umkehrosmosemembranen.
BR0112455A (pt) Métodos e dispositivos de sìntese contìnua de ferrato e métodos de tratamento, no local de uso, de uma mistura aquosa com, pelo menos, uma impureza, de purificação de água potável, de água de rejeito e de esgoto
DE60202169D1 (de) Verfahren zur Herstellung von Flockungsmittel zur Wasserbehandlung
DE60126722D1 (de) Aussprache von neuen Wörtern zur Sprachverarbeitung
DE60221619D1 (de) Verfahren zur Reinigung von Synthesegas
DK0828753T3 (da) A1/Fe-behandling af en proteinopløsning efterfulgt af membranopkoncentrering
DE602004006725D1 (de) Reinigung von Antikörpern durch Protein A und Ionenaustauschromatographie
ATE416610T1 (de) Wasserfilter
GB0100513D0 (en) Process
DE60120819D1 (de) Verfahren zur adsorptiven Trennung von Kohlendioxid
BR0114438A (pt) Processo e aparelho para o tratamento de água de despejo
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
AU2001272378A1 (en) Purification of protein inclusion bodies by crossflow microfiltration
ATE344321T1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
DE50206295D1 (de) Verfahren zur Aufbereitung von Industrieabwässern
DK1392314T3 (da) Hidtil ukendt anvendelse af 2-[2-ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]-triazin-4-on
DE60100565D1 (de) Verfahren zur Reinigung von Phosphatidylserin
DK1534404T3 (da) Anvendelse af en klatratmodifikator til at fremme passagen af proteiner under nanofiltrering
ATE338765T1 (de) Konzentrierung wässriger fraktionen von lisinopril durch umgekehrte osmose
ATE364389T1 (de) Verfahren zur herstellung von extrakten aus pelargonium sidoides und/oder pelargonium reniforme
ATE496939T1 (de) Methode zur reinigung von keratinozyten- wachstumfaktoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties